Steve Seedhouse
Steve Seedhouse is an analyst at Cantor Fitzgerald, who has compared AbCellera to Genentech, emphasizing its potential to become a significant player in the biotech industry, particularly with its innovative drug pipeline.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Steve Seedhouse is a Cantor Fitzgerald analyst who commented on the trial results.
7
Canada:
Steve Seedhouse is an analyst at Cantor Fitzgerald, referring to AbCellera as potentially Canada’s Genentech.
8